| Mapping genomic loci implicates genes and synaptic biology in schizophrenia V Trubetskoy, AF Pardiñas, T Qi, G Panagiotaropoulou, S Awasthi, ... Nature 604 (7906), 502-508, 2022 | 1089 | 2022 |
| The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder PK Maurya, C Noto, LB Rizzo, AC Rios, SOV Nunes, DS Barbosa, S Sethi, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 65, 134-144, 2016 | 185 | 2016 |
| Using deep belief network modelling to characterize differences in brain morphometry in schizophrenia WHL Pinaya, A Gadelha, OM Doyle, C Noto, A Zugman, Q Cordeiro, ... Scientific reports 6 (1), 38897, 2016 | 178 | 2016 |
| Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis C Noto, VK Ota, ES Gouvea, LB Rizzo, LMN Spindola, PHS Honda, ... International Journal of Neuropsychopharmacology 18 (4), pyu042, 2015 | 133 | 2015 |
| Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia E Asevedo, A Gadelha, C Noto, RB Mansur, A Zugman, SIN Belangero, ... Journal of psychiatric research 47 (10), 1376-1382, 2013 | 113 | 2013 |
| The role of aberrations in the immune-inflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia … C Roomruangwong, C Noto, B Kanchanatawan, G Anderson, M Kubera, ... Molecular neurobiology 57, 778-797, 2020 | 112 | 2020 |
| High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance C Noto, M Maes, VK Ota, AL Teixeira, RA Bressan, A Gadelha, E Brietzke The World Journal of Biological Psychiatry 16 (6), 422-429, 2015 | 97 | 2015 |
| Determinants of adherence to treatment in first-episode psychosis: a comprehensive review E Leclerc, C Noto, RA Bressan, E Brietzke Brazilian Journal of Psychiatry 37, 168-176, 2015 | 93 | 2015 |
| Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis MN Noto, M Maes, SOV Nunes, VK Ota, AC Rossaneis, WA Verri Jr, ... European Neuropsychopharmacology 29 (3), 416-431, 2019 | 81 | 2019 |
| Oxidative stress in drug naïve first episode psychosis and antioxidant effects of risperidone C Noto, VK Ota, A Gadelha, MN Noto, DS Barbosa, KL Bonifácio, ... Journal of psychiatric research 68, 210-216, 2015 | 74 | 2015 |
| Effects of depression on the cytokine profile in drug naive first-episode psychosis C Noto, VK Ota, ML Santoro, BB Ortiz, LB Rizzo, CH Higuchi, Q Cordeiro, ... Schizophrenia research 164 (1-3), 53-58, 2015 | 73 | 2015 |
| Depression, cytokine, and cytokine by treatment interactions modulate gene expression in antipsychotic naïve first episode psychosis C Noto, VK Ota, ML Santoro, ES Gouvea, PN Silva, LM Spindola, ... Molecular neurobiology 53 (8), 5701-5709, 2016 | 70 | 2016 |
| Factor structure of the Positive and Negative Syndrome Scale (PANSS) in Brazil: convergent validation of the Brazilian version CH Higuchi, B Ortiz, AA Berberian, C Noto, Q Cordeiro, SI Belangero, ... Brazilian Journal of Psychiatry 36, 336-339, 2014 | 63 | 2014 |
| Targeting the inflammatory pathway as a therapeutic tool for major depression C Noto, LB Rizzo, RB Mansur, RS McIntyre, M Maes, E Brietzke Neuroimmunomodulation 21 (2-3), 131-139, 2014 | 63 | 2014 |
| Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort ML Santoro, V Ota, S de Jong, C Noto, LM Spindola, F Talarico, E Gouvea, ... Translational psychiatry 8 (1), 174, 2018 | 61 | 2018 |
| Oxidative and nitrosative stress biomarkers in chronic schizophrenia KM Boll, C Noto, KL Bonifácio, CC Bortolasci, A Gadelha, RA Bressan, ... Psychiatry research 253, 43-48, 2017 | 52 | 2017 |
| Association of biomarkers and depressive symptoms in schizophrenia CS Noto, A Gadelha, SI Belangero, MAC Smith, BW de Aguiar, ... Neuroscience letters 505 (3), 282-285, 2011 | 52 | 2011 |
| Toward omics-based, systems biomedicine, and path and drug discovery methodologies for depression-inflammation research M Maes, G Nowak, JR Caso, JC Leza, C Song, M Kubera, H Klein, ... Molecular neurobiology 53, 2927-2935, 2016 | 49 | 2016 |
| Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway B Kanchanatawan, S Sirivichayakul, S Thika, K Ruxrungtham, ... Metabolic brain disease 32, 1003-1016, 2017 | 44 | 2017 |
| Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis FF Brinholi, C Noto, M Maes, KL Bonifácio, E Brietzke, VK Ota, A Gadelha, ... Schizophrenia research 166 (1-3), 225-230, 2015 | 43 | 2015 |
Rodrigo A BressanProfessor Adjunto Livre Docente, Universidade Federal de São PauloVerified email at unifesp.br
